Correlation Between Columbia Global and Biotechnology Fund

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Columbia Global and Biotechnology Fund at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Columbia Global and Biotechnology Fund into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Columbia Global Technology and Biotechnology Fund Class, you can compare the effects of market volatilities on Columbia Global and Biotechnology Fund and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Columbia Global with a short position of Biotechnology Fund. Check out your portfolio center. Please also check ongoing floating volatility patterns of Columbia Global and Biotechnology Fund.

Diversification Opportunities for Columbia Global and Biotechnology Fund

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between Columbia and Biotechnology is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Columbia Global Technology and Biotechnology Fund Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Fund Class and Columbia Global is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Columbia Global Technology are associated (or correlated) with Biotechnology Fund. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Fund Class has no effect on the direction of Columbia Global i.e., Columbia Global and Biotechnology Fund go up and down completely randomly.

Pair Corralation between Columbia Global and Biotechnology Fund

Assuming the 90 days horizon Columbia Global Technology is expected to generate 0.73 times more return on investment than Biotechnology Fund. However, Columbia Global Technology is 1.37 times less risky than Biotechnology Fund. It trades about 0.19 of its potential returns per unit of risk. Biotechnology Fund Class is currently generating about 0.01 per unit of risk. If you would invest  8,772  in Columbia Global Technology on September 4, 2024 and sell it today you would earn a total of  372.00  from holding Columbia Global Technology or generate 4.24% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Columbia Global Technology  vs.  Biotechnology Fund Class

 Performance 
       Timeline  
Columbia Global Tech 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Columbia Global Technology are ranked lower than 12 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak technical and fundamental indicators, Columbia Global may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Biotechnology Fund Class 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biotechnology Fund Class has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong technical and fundamental indicators, Biotechnology Fund is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Columbia Global and Biotechnology Fund Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Columbia Global and Biotechnology Fund

The main advantage of trading using opposite Columbia Global and Biotechnology Fund positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Columbia Global position performs unexpectedly, Biotechnology Fund can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Fund will offset losses from the drop in Biotechnology Fund's long position.
The idea behind Columbia Global Technology and Biotechnology Fund Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities